19th Sep 2005 07:00
Evolutec Group PLC19 September 2005 For immediate release 19 September 2005 EVOLUTEC GROUP PLC ("Evolutec" or "the Company") Notice of Interim Results Evolutec Group plc (AIM: EVC), the biopharmaceutical company developing novelproducts for the treatment of allergic, inflammatory and autoimmune diseases,will announce its Interim Results for the six months ended 30 June 2005 onWednesday 28 September 2005. A briefing for analysts will be held at 10:30am at the offices of BuchananCommunications, 107 Cheapside, London EC2, on the day of the resultsannouncement. For further information please contact: Buchanan Communications Tel: +44 (0) 20 7466 5000Mark Court, Tim Anderson, Mary-Jane Johnson This information is provided by RNS The company news service from the London Stock ExchangeRelated Shares:
Nanoco